Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Weisler, Richard H.
Biederman, Joseph
Spencer, Thomas J.
and
Wilens, Timothy E.
2005.
Long-Term Cardiovascular Effects of Mixed Amphetamine Salts Extended Release in Adults With ADHD.
CNS Spectrums,
Vol. 10,
Issue. S20,
p.
35.
Biederman, Joseph
Spencer, Thomas J.
Wilens, Timothy E.
Weisler, Richard H.
Read, Stephanie C.
and
Tulloch, Simon J.
2005.
Long-Term Safety and Effectiveness of Mixed Amphetamine Salts Extended Release in Adults With ADHD.
CNS Spectrums,
Vol. 10,
Issue. S20,
p.
16.
Spencer, Thomas J.
Biederman, Joseph
and
Wilens, Timothy E.
2005.
Efficacy and Tolerability of Long-Term, Open-Label, Mixed Amphetamine Salts Extended Release in Adolescents With ADHD.
CNS Spectrums,
Vol. 10,
Issue. S15,
p.
14.
Wilens, Timothy E.
Prince, Jefferson B.
Spencer, Thomas J.
and
Biederman, Joseph
2006.
Stimulants and Sudden Death: What Is a Physician to Do?.
Pediatrics,
Vol. 118,
Issue. 3,
p.
1215.
Vitiello, Benedetto
2008.
Understanding the Risk of Using Medications for Attention Deficit Hyperactivity Disorder with Respect to Physical Growth and Cardiovascular Function.
Child and Adolescent Psychiatric Clinics of North America,
Vol. 17,
Issue. 2,
p.
459.
Hammerness, Paul
Georgiopoulos, Anna
Doyle, Robert L.
Utzinger, Linsey
Schillinger, Mary
Martelon, MaryKate
Brodziak, Kerry
Biederman, Joseph
and
Wilens, Timothy E.
2009.
An Open Study of Adjunct OROS-Methylphenidate in Children Who Are Atomoxetine Partial Responders: II. Tolerability and Pharmacokinetics.
Journal of Child and Adolescent Psychopharmacology,
Vol. 19,
Issue. 5,
p.
493.
Hammerness, Paul
Wilens, Timothy
Mick, Eric
Spencer, Thomas
Doyle, Robert
McCreary, Michelle
Becker, Judith
and
Biederman, Joseph
2009.
Cardiovascular Effects of Longer-Term, High-Dose OROS Methylphenidate in Adolescents with Attention Deficit Hyperactivity Disorder.
The Journal of Pediatrics,
Vol. 155,
Issue. 1,
p.
84.
Silva, Raul R.
Skimming, Jeffrey W.
and
Muniz, Rafael
2010.
Cardiovascular Safety of Stimulant Medications for Pediatric Attention-Deficit Hyperactivity Disorder.
Clinical Pediatrics,
Vol. 49,
Issue. 9,
p.
840.
Stiefel, Gary
and
Besag, Frank M.C.
2010.
Cardiovascular Effects of Methylphenidate, Amphetamines and Atomoxetine in the Treatment of Attention-Deficit Hyperactivity Disorder.
Drug Safety,
Vol. 33,
Issue. 10,
p.
821.
Elia, Josephine
and
Vetter, Victoria L.
2010.
Cardiovascular Effects of Medications for the Treatment of Attention-Deficit Hyperactivity Disorder.
Pediatric Drugs,
Vol. 12,
Issue. 3,
p.
165.
Hammerness, Paul G.
Perrin, James M.
Shelley-Abrahamson, Rachel
and
Wilens, Timothy E.
2011.
Cardiovascular Risk of Stimulant Treatment in Pediatric Attention-Deficit/Hyperactivity Disorder: Update and Clinical Recommendations.
Journal of the American Academy of Child & Adolescent Psychiatry,
Vol. 50,
Issue. 10,
p.
978.
Rossi, Gian P.
Seccia, Teresa M.
Maniero, Carmela
and
Pessina, Achille C.
2011.
Drug-related hypertension and resistance to antihypertensive treatment.
Journal of Hypertension,
Vol. 29,
Issue. 12,
p.
2295.
Martinez-Raga, Jose
Knecht, Carlos
Szerman, Nestor
and
Martinez, María I.
2013.
Risk of Serious Cardiovascular Problems with Medications for Attention-Deficit Hyperactivity Disorder.
CNS Drugs,
Vol. 27,
Issue. 1,
p.
15.
Berg, Ansgar
Bråtane, Emelinn
Odland, Hans Henrik
Brudvik, Christina
Rosland, Bjørg
and
Hirth, Asle
2014.
Kardiovaskulær risikovurdering ved bruk av AD/HD-medikamenter hos barn.
Tidsskrift for Den norske legeforening,
Vol. 134,
Issue. 7,
p.
710.
Hennissen, Leonie
Bakker, Mireille J.
Banaschewski, Tobias
Carucci, Sara
Coghill, David
Danckaerts, Marina
Dittmann, Ralf W.
Hollis, Chris
Kovshoff, Hanna
McCarthy, Suzanne
Nagy, Peter
Sonuga-Barke, Edmund
Wong, Ian C. K.
Zuddas, Alessandro
Rosenthal, Eric
and
Buitelaar, Jan K.
2017.
Cardiovascular Effects of Stimulant and Non-Stimulant Medication for Children and Adolescents with ADHD: A Systematic Review and Meta-Analysis of Trials of Methylphenidate, Amphetamines and Atomoxetine.
CNS Drugs,
Vol. 31,
Issue. 3,
p.
199.
Wilkinson, James D.
Callicott, Ralph
Salminen, William F.
Sandhu, Satinder K.
Greenhaw, James
Paredes, Angel
Davis, Kelly
Jones, Yvonne
Paule, Merle G.
Slikker, William
Rusconi, Paolo G.
Czachor, Jason
Bodien, Amy
Westphal, Joslyn A.
Dauphin, Danielle D.
and
Lipshultz, Steven E.
2019.
A randomized controlled laboratory study on the long-term effects of methylphenidate on cardiovascular function and structure in rhesus monkeys.
Pediatric Research,
Vol. 85,
Issue. 3,
p.
398.
Hammerness, Paul
Berger, Amy
Angelini, Michael C.
and
Wilens, Timothy E.
2022.
Cardiovascular Considerations for Stimulant Class Medications.
Child and Adolescent Psychiatric Clinics of North America,
Vol. 31,
Issue. 3,
p.
437.
Idrees, Iman
Bellato, Alessio
Cortese, Samuele
and
Groom, Madeleine J.
2023.
The effects of stimulant and non-stimulant medications on the autonomic nervous system (ANS) functioning in people with ADHD: A systematic review and meta-analysis.
Neuroscience & Biobehavioral Reviews,
Vol. 144,
Issue. ,
p.
104968.